PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Anesth Analg. Author manuscript; available in PMC 2010 July 1.
Published in final edited form as:
PMCID: PMC2895314
NIHMSID: NIHMS208651

GABAA Receptor Alpha 4 Subunit Knockout Mice Are Resistant to the Amnestic Effect of Isoflurane

Abstract

Background

General anesthesia produces multiple endpoints including immobility, hypnosis, sedation and amnesia. Tonic inhibition via γ–aminobutyric acid type A receptors (GABAA-Rs) may play a role in mediating behavioral endpoints that are suppressed by low concentrations of anesthetics (e.g., hypnosis and amnesia). GABAA-Rs containing the α4 subunit are highly concentrated in the hippocampus and thalamus, and when combined with δ subunits they mediate tonic inhibition, which is sensitive to low concentrations of isoflurane.

Methods

The present study used a GABAA α4 receptor knockout mouse line to evaluate the contribution of α4-containing GABAAreceptors to the effects of immobility, hypnosis and amnesia produced by isoflurane. Knockout mice and their wild-type counterparts were assessed on three behavioral tests: conditional fear (to assess amnesia), loss of righting reflex (to assess hypnosis), and MAC, the minimum alveolar concentration of inhaled anesthetic necessary to produce immobility in response to noxious stimulation in 50% of subjects (to assess immobility).

Results

Genetic inactivation of the α4 subunit reduced the amnestic effect of isoflurane, minimally affected loss of righting reflex, and had no effect on immobility.

Conclusions

These results lend support to the hypothesis that different sites of action mediate different anesthetic endpoints and suggest that α4-containing GABAA-R are important mediators of the amnestic effect of isoflurane on hippocampal-dependent declarative memory.

INTRODUCTION

General anesthesia produces multiple endpoints including immobility, hypnosis, sedation and amnesia.1 Distinct neuronal pathways likely mediate these endpoints.2,3 The neurotransmitter γ–aminobutyric acid (GABA), through its action on GABA type A receptors (GABAA-Rs), plays a role in mediating these behavioral endpoints of anesthesia.4

GABAA-Rs are ligand-gated pentamers composed of several different subunits including α1–6, β1–3, γ1–3, δ, ε, π, θ and ρ1–3. Specific subunit combinations have unique anatomical distribution, pharmacological properties and functional significance.5 GABA acts on GABAA-Rs to produce two types of inhibitory actions, phasic inhibition and tonic inhibition.6,7 Phasic inhibition occurs when a high concentration of GABA is released from presynaptic vesicles, and postsynaptic GABAA-Rs are transiently activated resulting in an inhibitory postsynaptic potential. Tonic inhibition occurs when low concentrations of GABA in the extracellular space persistently activate extrasynaptic GABAA-Rs.

GABAA-Rs in the hippocampus contribute to the amnestic effect of anesthetics on learning and memory8,9, and GABAA-Rs in the thalamus are one site of action for the hypnotic effects of anesthetics.10 GABAA-Rs containing the α4 subunit are concentrated in the dentate gyrus of the hippocampus,11,12 and the dorsal thalamus12,13 and they mediate extrasynaptic inhibition.14 We previously demonstrated that α4-containing extrasynaptic receptors are essential for the cellular and behavioral responses of the sedative/hypnotic gaboxadol.14 Similarly, we demonstrated that α4-mediated extrasynaptic inhibition in the thalamus is markedly potentiated by isoflurane and this potentiation is absent in α4 knockout (KO) mice.15 Based on these studies, we hypothesized that as with gaboxadol, α 4-containing receptors may mediate some of the behavioral effects of isoflurane.

The present study used a GABAA α4 receptor KO mouse line14 to evaluate the contribution of α4-containing GABAA receptors to the effects of amnesia, hypnosis, and immobility produced by isoflurane. We assessed KO mice and their wild-type (WT) counterparts on three behavioral tests: conditional fear (to assess amnesia), loss of righting reflex (to assess hypnosis), and MAC, the minimum alveolar concentration of inhaled anesthetic necessary to produce immobility in response to noxious stimulation in 50% of subjects (to assess immobility).

METHODS

Mice

Homozygous α4 KO and WT littermate controls were created by breeding mice heterozygous for the GABAA-R α4 subunit KO allele.14 Mice were of the F3–4 generations and their genetic background was a mixture of C57BL/6J and Strain 129S1/X1. At weaning, mice were genotyped using Southern Blot analysis of tail DNA as previously described.14 Mice were group housed, were kept on a 12 hour alternating light/dark cycle, and were allowed access to food and water ad libitum. All protocols were approved by the committees on animal care and use at the University of California, San Francisco and at the University of Pittsburgh.

Fear Conditioning

Mice were assessed for isoflurane-induced amnesia by fear conditioning. Eight to 12 mice of each genotype and sex were assessed at each concentration. Prior to fear conditioning, groups of mice were placed in a chamber (28 cm L × 12.5 cm W × 17.5 cm H) equilibrated with the desired isoflurane concentration. Isoflurane concentrations tested included: 0.0%, 0.1%, 0.2%, 0.3%, 0.4%, 0.6%, and 0.8% atm. A Gow-Mac gas chromatograph (Gow-Mac Instrument Corp., Bridgewater, NJ) equipped with a flame ionization detector was used to measure concentrations of isoflurane.

After 30 minutes of equilibration, the mice were quickly transferred to the training chambers, which contained the same isoflurane concentration as in the equilibration chamber. The chambers (27 cm L × 24.5 cm W × 20 cm H) were constructed of clear acrylic. The grid floor used to deliver shock was composed of 31 stainless steel bars, each 3 mm in diameter, spaced 7 mm center to center. These floors were connected to a shock delivery system (San Diego Instruments, San Diego, CA). The chambers were wiped down with a pine-scented cleaner (5% Pine Scented Disinfectant, Midland, Inc.; Sweetwater, TN) before and after each session. In the room in which training took place, the overhead fluorescent bulbs were left on and a ventilation fan provided background noise (65 db). The lighting, background noise, appearance, odor, and texture of the chambers and room comprised the training context.

After a 3 min period in the chambers, the mice received 3 tone (2000 Hz, 90 db)-shock (1 mA, 2 s) pairings, separated by 1 min. During training, freezing was scored only in animals receiving 0% isoflurane. This is because freezing may be visually difficult to distinguish from sedation in mice treated with isoflurane, thus confounding scoring procedures. Freezing, the absence of all movement except that necessary for respiration, is an innate defensive response in rodents and is a reliable measure of learned fear.16,17 Each animal’s behavior was scored every 8 s during the observation period and a percentage was calculated by dividing the number of freezing observations a mouse had by the total number possible during the observation period.

The following day, mice were tested for fear to the training context and fear to tone. For the context test, each mouse was placed back in the chamber in which it was trained for a period of 8 min (in the absence of shock). For the tone test, groups of mice were transported in separate plastic pots (14 cm high × 15.5 cm diameter) to a different context in a different room. The test chambers were triangular in shape with an acrylic floor (28 cm L × 25 cm W) and two acrylic sidewalls (28 cm L × 22 cm W) at a 45° angle. The chambers were equipped with a speaker and were wiped down with acetic acid (1%, Fisher Scientific) before and after each session. The room appeared dark to the mice, being lit by a single red 30 W bulb. White noise (65 dB) was used for background noise. Mice were given a 3 min exploratory period, then 6 30 s tones (2000 Hz, 90 db) were presented, separated by 60 s. As with the context test, no shocks were administered during the tone test. Animals were removed from the chamber after an additional 30 s. The order of the context and tone tests was counterbalanced, such that half of each treatment group was tested to context first and tone second and vice versa. Context and tone tests were spaced at least an hour apart. Freezing was scored during training and both tests.

Loss of Righting Reflex

Mice (10–20 weeks of age) were tested for halothane (n=7 males (M), 9 females (F)/genotype) and isoflurane (WT: n=2M, 9F; KO: n=4M, 9F) -induced loss of righting reflex as previously described.18 Controlled concentrations of halothane (Halocarbon Laboratories, River Edge, NJ) or isoflurane (Abbot Laboratories, North Chicago, IL) were delivered to the testing chambers by means of agent-specific vaporizers. A Datomex Capnomac Ultima device continuously monitored the concentration of anesthetic gas within the chamber. The mice were equilibrated with anesthetic for 15 minutes and then scored for the righting reflex while the carousel rotated at 4 rpm. After testing at one concentration of anesthetic, the mice were allowed to recover in anesthetic-free air for 20 min. Anesthetic gas concentrations tested ranged from 0.6%–1.1% atm with an increment of 0.1% in each trial.

MAC

Mice (10–20 weeks of age) were monitored for response to noxious stimuli in the presence of the halothane (n=7M, 9F/genotype) and isoflurane (WT: n=12M, 14F; KO: n=13M, 14F) using the tail clamp-withdrawal assay as described.18 Following equilibration with anesthetic, a hemostat was applied to the tail and the mouse was scored for purposeful, gross movement in response to the tail clamp. Mice were allowed to recover for 15 minutes in air before testing at the next concentration. The range of concentrations tested was 1.0%–1.8% with 0.2% increments.

Statistical Analysis

For loss of righting reflex and MAC assays, half maximal effective concentration values (EC50) were obtained from concentration response data using the iterative nonlinear least-squares method as previously described 19 for quantal responses.18 The Z statistic was used to compare genotypes on both assays.20 Because of the limited number of genetically engineered mice available for these studies, males and females were combined for analysis. Previous studies demonstrated that males and females respond similarly on the behavioral assays of loss of righting reflex and MAC in response to anesthetics.21,22 Data are presented as EC50 ± SEM.

For fear conditioning, analysis of variance (ANOVA) was used to analyze freezing scores during training, and nonlinear regression was used to calculate EC50 values and the maximum value of the dose response curve for context and tone freezing scores. The following equation was used in the regression, with n=the Hill coefficient, and A=the maximal value

equation M1

RESULTS

Fear Conditioning

Pilot data suggested that male and female WT mice showed differences in freezing scores at 0% isoflurane. Given these results, we analyzed data from male and female mice separately.

Training

Freezing during training was only scored in mice receiving 0% isoflurane. This is because freezing may be visually difficult to distinguish from sedation in mice treated with isoflurane, thus confounding scoring procedures. All mice regardless of genotype or sex showed increased freezing over the duration of training, with all groups arriving at the same level of freezing by the third tone-shock presentation (Figure 1). This observation was confirmed with a repeated measures ANOVA with genotype and sex as factors. Freezing significantly increased with each tone-shock presentation during training, F(4, 168) = 48.50, P<0.0001, but there was no reliable effect of genotype or sex and no interactions.

Figure 1
Conditional freezing during training. Training consisted of three tones (labeled here at “T”) that coterminated each with a shock. Freezing, scored during tones and after (Post-Tones: “PT) significantly increased over the tone-shock ...

Context Test

The isoflurane EC50s for female WT and KO mice were 0.08 ± 0.03% and 0.28 ± 0.03%, respectively (Figure 2). A t-test revealed a statistically significant difference between these EC50 measures (P<0.005). Female WT and KOs did not differ significantly at 0% isoflurane.

Figure 2
The dose response curve and EC50 values for female WT and KO mice for fear to context. There was a statistically significant shift between the EC50 for female WT mice (0.082 ± 0.03% isoflurane) and the EC50 for female KO mice (0.28 ± 0.03% ...

There was no statistical difference between the isoflurane EC50s for male WT mice (0.16 ± 0.05% isoflurane) and male KO mice (0.14 ± 0.03% isoflurane), as shown in Figure 3. However, male mice differed (P<0.05) on context freezing scores at 0% isoflurane (30.41 ± 8.59% for WT vs. 55.29 ± 6.78% for KO). Because of this difference in freezing at 0% isoflurane, it was not possible to accurately compare EC50 values for WT and KO mice. To address this issue in a manner that would allow for a valid comparison of genotypes, we conducted a follow-up experiment in which freezing levels were made equivalent in male WT and KO mice at 0% isoflurane by training them with 6 tone-shock pairings (versus 3 tone-shock pairings in the original experiment). We subsequently tested both genotypes at the EC50 for WT mice for fear to context, 0.16% isoflurane, and the EC50 for WT mice for fear to tone, 0.52% isoflurane. When freezing was equated between male WT and KO at 0% isoflurane, an effect of genotype on freezing scores was observed, F(1, 34) = 4.19, P<0.05; Figure 4). There was also a trend toward an interaction between genotype and isoflurane, F(1,34) = 3.35, P=0.076. Preplanned comparisons show that KO were reliably higher than WT at both 0.16% and 0.52% isoflurane (P<.05). Thus, while 0.16% isoflurane had no effect on knockout mice trained with the 6 shock paradigm, it had a significant effect on the wildtypes littermates.

Figure 3
The dose response curves and EC50 values for context freezing for male WT mice and male KO mice. There was no statistical difference between the mice (0.16 ± 0.05% isoflurane) versus male KO mice (0.14 ± 0.03% isoflurane). However, male ...
Figure 4
When freezing was equated between male WT and KO by increasing the number of shocks during training from 3 to 6, there was a reliable effect of genotype on context freezing scores at the EC50 value for context conditioning in WT male mice, 0.16% isoflurane, ...

Tone Test

The EC50 for female WT mice was 0.43 ± 0.06% isoflurane, and the EC50 for female KO mice was 0.43 ± 0.06% isoflurane (Figure 5). A t-test revealed no significant difference between these EC50 measures. There was no difference at 0% isoflurane between female WT and KO mice.

Figure 5
Concentration response curves and EC50 values for female WT and KO mice for fear to tone. The female WT EC50 (0.43 ± 0.06% isoflurane) did not differ from the female KO EC50 (0.43 ± 0.06% isoflurane).

The EC50 for male WT mice was 0.52 ± 0.08% isoflurane, and the EC50 for male KO mice was 0.42 ± 0.06% isoflurane (Figure 6). A t-test revealed no significant difference between these EC50 measures. Fear to tone was also measured in the follow-up experiment with 6 shocks described in the previous section. There was no reliable difference in fear to tone between WT and KO mice in this follow-up study as determined by ANOVA.

Figure 6
Concentration response curves and the EC50 values for male WT and KO mice for fear to tone. Male WT mice did not differ form KO mice on their EC50 values (0.52 ± 0.08% isoflurane vs. 0.42 ± 0.06% isoflurane).

Loss of Righting Reflex

For isoflurane-induced loss of righting reflex (Figure 7), the EC50 for WT (0.73 ± 0.02) and KO (0.74 ± 0.02) mice did not differ. For halothane-induced loss of righting reflex (Figure 8), the EC50 for KO mice (0.90 ± 0.01) was increased (P<0.05) compared to WT controls (0.84 ± 0.02).

Figure 7
For isoflurane-induced loss of righting reflex (LORR), the EC50 for WT (0.73 ± 0.02) and KO (0.74 ± 0.02) mice did not differ. The MAC value also did not differ between WT and KO (WT EC50=1.45 ± 0.03 vs. KO=1.37 ± 0.03). ...
Figure 8
For halothane-induced loss of righting reflex (LORR), the EC50 for KO mice (0.90 ± 0.01) was increased (p<0.05) compared to WT controls (0.84 ± 0.02). The MAC value did not differ between WT and KO (WT EC50=1.61 ± 0.03 ...

MAC

WT and KO mice did not differ in their isoflurane MAC (also shown in Figure 7) (WT EC50=1.45 ± 0.03 vs. KO=1.37 ± 0.03). Similarly, genotype did not affect response to halothane (also shown in Figure 8) on this assay (WT EC50=1.61 ± 0.03 vs. KO=1.59 ± 0.03).

DISCUSSION

In this study, we tested the role of α4-containing GABAA-Rs in behavioral responses to isoflurane and halothane. We found that GABAA-R α4 KO mice were resistant to the effects of isoflurane on learning and memory. In other words, genetic inactivation of the α4 subunit reduced the amnestic effect of isoflurane. In contrast, KO of α4 slightly but significantly affected loss of righting reflex for halothane but not for isoflurane, and had no effect on immobility as determined by MAC for either isoflurane or halothane.

KO mice were resistant to isoflurane’s effect on context conditioning, but not conditioning to tone. This finding is consistent with the observations that GABAA α4-containing receptors are highly expressed in the hippocampus11,12, and the hippocampus is selectively involved in fear conditioned to context, but not tone. The basolateral amygdala is the site at which convergence of information about the shock and its predictive cues occurs.23 The roles of the amygdala and hippocampus in fear conditioning have been well characterized. Lesions of the amygdala block fear to tone and context, whereas lesions of the hippocampus block only fear to context and leave fear to tone intact.24,25 Our findings and the selective role of the hippocampus in fear conditioned to context suggest a specific role for the GABAA α4 receptor subtype in inhaled anesthetic-induced impairment of hippocampal-dependent learning.

While the majority of hippocampal GABAA α4 receptors co-localize with the δ subunit extrasynaptically, there is a substantial portion of GABAA α4 containing receptors that co-localize synaptically with the GABAA γ2 subunit.11 Therefore, it is possible that isoflurane produces its suppression of learning and memory by extrasynaptic as well as synaptic inhibition. However, this is likely related to isoflurane concentration. We have shown previously that knockout of the GABAA α1 receptor subunit, which is thought to primarily mediate phasic inhibition26,27 also produces a resistance to the amnestic effects of isoflurane.8 The EC50 for GABAA α1 WT mice (males and females combined) was approximately 0.15% isoflurane, and the EC50 for GABAA α1 KO mice was approximately 0.37% isoflurane.8 This is much higher for the KO in comparison to the results in this study: EC50 for GABAA α4 WT mice (averaged between males and females) was 0.12% isoflurane while the EC50 for GABAA α4 KO mice 0.21% isoflurane. While the EC50 values for both GABAAα1 and α4 WTs are similar, more isoflurane was necessary to suppress freezing by 50% in the GABAA α1 KO than the α4 KO. This is consistent with the finding that isoflurane at a very low concentration (25 μM) directly activates GABAA-R containing the α4 subunit, but only higher concentrations (higher than 200 μM) are able to directly activate GABAA-R containing the α1 subunit.28

There was no significant difference between WT and KO mice on isoflurane-induced loss of righting reflex. However, a modest, but statistically significant difference on halothane-induced loss of righting reflex was observed between genotypes. The halothane EC50 that was required to suppress this response in KO mice was increased by approximately 7% compared to WT mice. We are uncertain as to the biological significance of this modest change in anesthetic response. We also cannot rule out that compensatory responses may lead to over - or underestimation of the true contribution of α4-containing receptors to anesthetic-induced loss of righting. Nonetheless, we conclude that α4-containing GABAA-Rs are not required for mediating the hypnotic effect of inhaled anesthetics.

Lastly, we observed no effect of α4 gene KO on immobility in response to halothane or isoflurane as measured by MAC. These results are consistent with previous pharmacologic studies that have demonstrated that GABAA-Rs in the spinal cord are not key mediators of anesthetic-induced immobility.29,30

The present results lend support to the hypothesis that different sites of action mediate different anesthetic endpoints. GABAA-Rs containing the α4 subunit play little if any role in inhaled anesthetic-induced hypnosis and immobility. In contrast, these receptors are key mediators/modulators of inhaled anesthetic-induced amnesia. GABAA-Rs containing the α4 subunit are important for hippocampal-dependent fear to context but not hippocampal-independent fear to tone. These results support an important role for α4 containing GABAA-Rs specifically on hippocampal-dependent types of memory like declarative memory.

Acknowledgments

NIH grant 1P01GM47818 supported part of this work

Footnotes

Dr. Eger is a paid consultant to Baxter Healthcare Corp, who donated the isoflurane used in some of these studies.

References

1. Rudolph U, Antkowiak B. Molecular and neuronal substrates for general anaesthetics. Nat Rev Neurosci. 2004;5:709–20. [PubMed]
2. Campagna JA, Miller KW, Forman SA. Mechanisms of actions of inhaled anesthetics. N Engl J Med. 2003;348:2110–24. [PubMed]
3. Eger EI, 2nd, Koblin DD, Harris RA, Kendig JJ, Pohorille A, Halsey MJ, Trudell JR. Hypothesis: inhaled anesthetics produce immobility and amnesia by different mechanisms at different sites. Anesth Analg. 1997;84:915–8. [PubMed]
4. Bonin RP, Orser BA. GABA(A) receptor subtypes underlying general anesthesia. Pharmacol Biochem Behav. 2008;90:105–12. [PubMed]
5. Sieghart W, Sperk G. Subunit composition, distribution and function of GABA(A) receptor subtypes. Curr Top Med Chem. 2002;2:795–816. [PubMed]
6. Farrant M, Nusser Z. Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat Rev Neurosci. 2005;6:215–29. [PubMed]
7. Mody I, Pearce RA. Diversity of inhibitory neurotransmission through GABA(A) receptors. Trends Neurosci. 2004;27:569–75. [PubMed]
8. Sonner JM, Cascio M, Xing Y, Fanselow MS, Kralic JE, Morrow AL, Korpi ER, Hardy S, Sloat B, Eger EI, 2nd, Homanics GE. Alpha 1 subunit-containing GABA type A receptors in forebrain contribute to the effect of inhaled anesthetics on conditioned fear. Mol Pharmacol. 2005;68:61–8. [PubMed]
9. Caraiscos VB, Newell JG, You-Ten KE, Elliott EM, Rosahl TW, Wafford KA, MacDonald JF, Orser BA. Selective enhancement of tonic GABAergic inhibition in murine hippocampal neurons by low concentrations of the volatile anesthetic isoflurane. J Neurosci. 2004;24:8454–8. [PubMed]
10. Belelli D, Peden DR, Rosahl TW, Wafford KA, Lambert JJ. Extrasynaptic GABAA receptors of thalamocortical neurons: a molecular target for hypnotics. J Neurosci. 2005;25:11513–20. [PubMed]
11. Sun C, Sieghart W, Kapur J. Distribution of alpha1, alpha4, gamma2, and delta subunits of GABAA receptors in hippocampal granule cells. Brain Res. 2004;1029:207–16. [PMC free article] [PubMed]
12. Khan ZU, Gutierrez A, Mehta AK, Miralles CP, De Blas AL. The alpha 4 subunit of the GABAA receptors from rat brain and retina. Neuropharmacology. 1996;35:1315–22. [PubMed]
13. Sur C, Farrar SJ, Kerby J, Whiting PJ, Atack JR, McKernan RM. Preferential coassembly of alpha4 and delta subunits of the gamma-aminobutyric acidA receptor in rat thalamus. Mol Pharmacol. 1999;56:110–5. [PubMed]
14. Chandra D, Jia F, Liang J, Peng Z, Suryanarayanan A, Werner DF, Spigelman I, Houser CR, Olsen RW, Harrison NL, Homanics GE. GABAA receptor alpha 4 subunits mediate extrasynaptic inhibition in thalamus and dentate gyrus and the action of gaboxadol. Proc Natl Acad Sci U S A. 2006;103:15230–5. [PubMed]
15. Jia F, Yue M, Chandra D, Homanics GE, Goldstein PA, Harrison NL. Isoflurane is a potent modulator of extrasynaptic GABA(A) receptors in the thalamus. J Pharmacol Exp Ther. 2008;324:1127–35. [PubMed]
16. Fanselow MS. Conditioned and unconditional components of post-shock freezing. Pavlov J Biol Sci. 1980;15:177–82. [PubMed]
17. Fanselow MS. Neural organization of the defensive behavior system responsible for fear. Psychonomic Bulletin and Review. 1994;1:429–438. [PubMed]
18. Homanics GE, Ferguson C, Quinlan JJ, Daggett J, Snyder K, Lagenaur C, Mi ZP, Wang XH, Grayson DR, Firestone LL. Gene knockout of the alpha6 subunit of the gamma-aminobutyric acid type A receptor: lack of effect on responses to ethanol, pentobarbital, and general anesthetics. Mol Pharmacol. 1997;51:588–96. [PubMed]
19. Waud D. On biologic assays involving quantal responses. The Journal of Pharmacology and Experimental Therapeutics. 1972;183:577–697. [PubMed]
20. Alifimoff JK, Firestone LL, Miller KW. Anesthetic potencies of secondary alcohol enantiomers. Anesthesiology. 1987;66:55–9. [PubMed]
21. Mazze RI, Rice SA, Baden JM. Halothane, isoflurane, and enflurane MAC in pregnant and nonpregnant female and male mice and rats. Anesthesiology. 1985;62:339–41. [PubMed]
22. Flood P, Sonner JM, Gong D, Coates KM. Heteromeric nicotinic inhibition by isoflurane does not mediate MAC or loss of righting reflex. Anesthesiology. 2002;97:902–5. [PubMed]
23. Maren S, Fanselow M. The amygdala and fear conditioning: Has the nut been cracked? Neuron. 1996:16. [PubMed]
24. Kim JJ, Fanselow MS. Modality-specific retrograde amnesia of fear. Science. 1992;256:675–7. [PubMed]
25. Phillips RG, LeDoux JE. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci. 1992;106:274–85. [PubMed]
26. Prenosil GA, Schneider Gasser EM, Rudolph U, Keist R, Fritschy JM, Vogt KE. Specific subtypes of GABAA receptors mediate phasic and tonic forms of inhibition in hippocampal pyramidal neurons. J Neurophysiol. 2006;96:846–57. [PubMed]
27. Nusser Z, Sieghart W, Somogyi P. Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells. J Neurosci. 1998;18:1693–703. [PubMed]
28. Raines DE, Claycomb RJ, Forman SA. Modulation of GABA(A) receptor function by nonhalogenated alkane anesthetics: the effects on agonist enhancement, direct activation, and inhibition. Anesth Analg. 2003;96:112–8. table of contents. [PubMed]
29. Zhang Y, Sonner JM, Eger EI, 2nd, Stabernack CR, Laster MJ, Raines DE, Harris RA. Gamma-aminobutyric acidA receptors do not mediate the immobility produced by isoflurane. Anesth Analg. 2004;99:85–90. [PubMed]
30. Kim J, Atherley R, Werner DF, Homanics GE, Carstens E, Antognini JF. Isoflurane depression of spinal nociceptive processing and minimum alveolar anesthetic concentration are not attenuated in mice expressing isoflurane resistant gamma-aminobutyric acid type-A receptors. Neurosci Lett. 2007;420:209–12. [PMC free article] [PubMed]